RXMD Fair Market Value now = 38 cents/share (up to 80 cents per share*): Market cap of a company in this sector (Drugs/Pharmaceutical; http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/psdata.html )easily reaches 4.75x the P/S ratio (up to 10x*)...so for an estimated 50M revs the RXMD fair market value (and 628M OS; preserved btw), not even taking its constant expansion into account, should be at a pps of 38 cents in a conservative evaluation (up to 88 cents* pps).